Launch Overview
Zimmer Biomet Holdings, Inc. (NYSE: ZBH) and its Indian subsidiary announced on 26 October 2026 the launch of ROSA® Knee with OptimiZe™ in India, an enhanced version of the ROSA® Knee System intended for personalized robotic‑assisted total knee replacement surgery.
Technology Enhancements
The system introduces three new features: OptimiZe Planning™ creates customized surgical plans that guide implant positioning based on each patient’s anatomy and the surgeon’s knee‑balancing preferences; OptimiZe Landmarking™ employs a bone‑painting technique to reduce variability in landmark identification; and OptimiZe Tracking™ utilizes motion‑sensitive Active Track™ technology, removing the need to pin the cut guide to bone and keeping bone resections on plane even when the leg moves.
Executive Commentary
Ajay Bagga, Managing Director and Country Head of Zimmer India Pvt. Ltd, stated that orthopaedic care is moving toward more personalized approaches and that the launch reflects the company’s commitment to delivering tools that enhance consistency in surgical planning and execution.
Data Analytics Integration
ROSA® Knee with OptimiZe™ is integrated with ZBEdge® Analytics, Zimmer Biomet’s data‑analytics platform, providing surgeons with data‑driven insights to support informed clinical decision‑making.
Strategic Context
The launch builds on Zimmer Biomet’s ongoing investment in robotic‑assisted technologies in India, complementing its Global Capability Center presence and leveraging its 99‑year legacy of delivering mobility‑enhancing medical‑technology solutions.
Company Background
Zimmer Biomet is a global medical‑technology leader offering a comprehensive portfolio of digital and robotic products designed to improve patient outcomes and enable data‑enabled clinical decisions.